Peter J. Lang

Peter J. Lang's AcademicInfluence.com Rankings

Peter J. Lang

Philosophy

#11018

World Rank

#15134

Historical Rank

Logic

#7844

World Rank

#9747

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Peter J. Lang's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Peter J. Lang Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Peter J. Lang's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Determinants of Antileukemia Effects of Allogeneic NK Cells 1 (2004) (430)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. (2010) (399)
Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation (2006) (375)
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia (2010) (303)
Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children (2001) (290)
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? (2004) (234)
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. (2013) (228)
Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies (2013) (222)
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. (1995) (215)
Adherent Platelets Recruit and Induce Differentiation of Murine Embryonic Endothelial Progenitor Cells to Mature Endothelial Cells In Vitro (2006) (201)
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. (2008) (175)
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. (2015) (166)
Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. (1999) (156)
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. (2008) (146)
Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. (2009) (141)
Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia (2011) (138)
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children (1999) (137)
Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients (2015) (134)
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications. (2015) (132)
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab (2014) (129)
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. (2014) (124)
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. (2015) (122)
Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. (2013) (122)
Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting (1998) (116)
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial. (2015) (113)
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts (2016) (113)
Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. (2004) (112)
Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents – a Berlin–Frankfurt–Münster group report (2006) (111)
Transplantation of Megadoses of Purified Haploidentical Stem Cells (1999) (111)
Long-term outcome after haploidentical stem cell transplantation in children. (2004) (111)
Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. (2005) (109)
Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. (2003) (108)
Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation (2005) (106)
Exploitation of natural killer cells for the treatment of acute leukemia. (2016) (104)
Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors (2004) (101)
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective (2004) (101)
A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen‐disparate haematopoietic stem cells from parental donors (2001) (101)
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia (2014) (99)
Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation (2008) (98)
Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study. (1998) (93)
Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. (2011) (93)
Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. (2006) (91)
Adenovirus infection after allogeneic stem cell transplantation (2007) (82)
Long-Term Human CD34+ Stem Cell-Engrafted Nonobese Diabetic/SCID/IL-2Rγnull Mice Show Impaired CD8+ T Cell Maintenance and a Functional Arrest of Immature NK Cells (2010) (79)
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis. (2016) (78)
Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children (2010) (77)
A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. (2005) (76)
Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects. (2006) (76)
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM) (2018) (74)
Feasibility and Outcome of Reduced‐Intensity Conditioning in Haploidentical Transplantation (2007) (72)
Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey (2016) (69)
Haploidentical transplantation for acute lymphoblastic leukemia in childhood. (2004) (68)
Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children (2002) (65)
Preliminary evaluation of one conventional nested and two real-time PCR assays for the detection of Toxoplasma gondii in immunocompromised patients. (2004) (62)
Haploidentical SCT in children: an update and future perspectives (2008) (60)
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation (2012) (58)
A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors (2003) (57)
Adoptive transfer of pp 65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation (2010) (57)
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. (2004) (56)
Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation (2012) (55)
Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma. (1997) (52)
Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children (1999) (51)
Immunological Aspects of Haploidentical Stem Cell Transplantation in Children (2001) (51)
Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation (2013) (50)
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia (2007) (50)
High Proportion of Leukemic Stem Cells at Diagnosis Is Correlated with Unfavorable Prognosis in Childhood Acute Myeloid Leukemia (2011) (48)
Monocyte-Induced Development of Th17 Cells and the Release of S100 Proteins Are Involved in the Pathogenesis of Graft-versus-Host Disease (2014) (48)
Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease. (2005) (48)
Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma (2002) (47)
Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD (2014) (46)
Chronic Inflammatory Bowel Disease as Key Manifestation of Atypical ARTEMIS Deficiency (2010) (46)
Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma. (2018) (46)
Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery (2002) (46)
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL‐SCT 2003/2007 trial (2018) (45)
Intensity of HLA class I expression and KIR‐mismatch determine NK‐cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia (2007) (44)
Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. (2005) (44)
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (43)
Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome (2013) (41)
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. (2006) (40)
γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay (2014) (39)
Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation (2007) (37)
Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects (2003) (37)
Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients (2014) (37)
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre‐emptive immunotherapy (2005) (37)
Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases (2004) (37)
Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis (2012) (36)
Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report (2016) (36)
Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia (2004) (35)
Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS (2021) (35)
Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions (2010) (34)
GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells (2019) (33)
CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation (2018) (33)
Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. (2005) (33)
Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors. (2002) (33)
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation (2017) (32)
Late effects after stem cell transplantation (SCT) in children – growth and hormones (2005) (31)
Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation (2005) (30)
Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatment. (2014) (30)
Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia (2020) (30)
Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news? (2003) (30)
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation “MSC-FFM”—Outcome Report of 92 Patients (2019) (29)
Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease (2019) (29)
NK Cell immunotherapy for high‐risk neuroblastoma relapse after haploidentical HSCT (2012) (28)
Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells (2008) (28)
High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia. (2010) (27)
Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19 (2021) (27)
Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones (2009) (27)
Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice. (2010) (26)
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia (2016) (26)
The history and future prospective of haplo-identical stem cell transplantation. (2008) (26)
Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia (2007) (25)
Outcome of allogeneic stem cell transplantation in children with non-malignant diseases. (2006) (25)
Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. (2004) (24)
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment (2013) (24)
Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia (2004) (24)
Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. (2008) (24)
Allo-SCT using BU, CY and melphalan for children with AML in second CR (2013) (23)
Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma (2014) (23)
Treatment of graft failure with TNI‐based reconditioning and haploidentical stem cells in paediatric patients (2016) (23)
Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study (2017) (23)
NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML (2015) (23)
Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations. (2006) (23)
IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT (2012) (23)
Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or bone marrow? (2014) (22)
Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia. (2020) (22)
Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice. (2014) (20)
Cellular immune reconstitution after haploidentical transplantation in children. (2008) (20)
Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors. (2011) (19)
Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation. (2010) (19)
Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipient. (2009) (19)
Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic cells. (2006) (18)
Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation. (2016) (18)
Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy (2015) (18)
Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. (2019) (17)
Adoptive T-cell Transfer for Refractory Viral Infections with Cytomegalovirus, Epstein-Barr Virus or Adenovirus after Allogeneic Stem Cell Transplantation (2013) (17)
Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children. (2011) (17)
Generation of suppressive blood cells for control of allograft rejection. (2015) (17)
Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response. (2010) (17)
Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells. (1989) (17)
Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT (2015) (17)
OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. (2000) (17)
Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. (2005) (16)
Positive selection of CD56+ lymphocytes by magnetic cell sorting. (1996) (16)
Influence of a mutation in IFN-γ receptor 2 (IFNGR2) in human cells on the generation of Th17 cells in memory T cells. (2013) (16)
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody. (2016) (16)
Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing’s sarcoma patients (2015) (16)
WT1 protein expression in childhood acute leukemia (2008) (16)
Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization. (1995) (16)
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL (2019) (15)
Increase of Intermediate Monocytes in Graft-versus-Host Disease: Correlation with MDR1+Th17.1 Levels and the Effect of Prednisolone and 1α,25-Dihydroxyvitamin D3. (2017) (14)
CNS progression during vinblastine or targeted therapies for high‐risk relapsed ALK‐positive anaplastic large cell lymphoma: A case series (2018) (14)
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial (2019) (14)
Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC) (2020) (14)
Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors. (2004) (13)
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients (2021) (13)
Haploidentical stem cell transplantation and subsequent immunotherapy with antiGD2 antibody for patients with relapsed metastatic neuroblastoma. (2015) (13)
Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial (2019) (13)
Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia (2011) (13)
Outcomes of pediatric identical living‐donor liver and hematopoietic stem cell transplantation (2016) (12)
Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy (2020) (12)
Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBG. (1994) (12)
Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia (2013) (12)
Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients (2015) (11)
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells. (2004) (11)
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high‐risk or relapsed ALL – results of the ALL‐SCT 2003 trial (2018) (11)
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation (2015) (11)
OKT‐3‐based reconditioning regimen for early graft failure in HLA‐non‐identical stem cell transplants (2000) (11)
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study. (2019) (11)
CD155 is involved in NK-cell mediated lysis of human hepatoblastoma in vitro. (2011) (11)
CD34 stem cell dose and development of extensive chronic graft-versus-host disease. (2002) (11)
Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells. (2010) (10)
Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago (2004) (10)
Fibrinolysis shut down in COVID-19 patients: Report on two severe cases with potential diagnostic and clinical relevance (2020) (10)
Granulocyte colony-stimulating factor induced pulmonary hemorrhage in a healthy stem cell donor. (2007) (10)
Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity (2003) (10)
Consensus of German Transplant Centers on Hematopoietic Stem Cell Transplantation in Fanconi Anemia (2015) (10)
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting (2020) (9)
Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias. (2002) (9)
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment (2021) (9)
Quantitative Monitoring of Minimal Residual Disease after Allogeneic Stem Cell Transplantation in Relapsed Childhood ALL Allows the Identification of Impending Relapse – Results of the ALL BFM SCT 2003 Trial (2014) (9)
Defibrotide for the treatment of PIMS-TS in two pediatric patients. (2020) (9)
TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial (2016) (9)
Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles (2018) (8)
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016. (2018) (7)
Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature (2019) (7)
Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial (2017) (7)
Stem cell transplantation for polycythemia vera (2008) (7)
Surgical management of stem cell transplantation‐related complications in children (2012) (7)
Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation (2014) (7)
Long-Term Remission After First-Line Single-Agent Treatment with Arsenic Trioxide of Relapsed Acute Promyelocytic Leukemia in an 8-Year-Old Boy (2011) (7)
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning (2020) (6)
Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients (2019) (6)
KIR B haplotype donors confer a reduced risk of relapse after haploidentical transplantation in children with acute lymphoblastic leukemia (2014) (6)
In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cells. (1990) (6)
131I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced Tumors (2021) (6)
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity (2019) (5)
Fulminant Rhizomucor pusillus mucormycosis during anti-leukemic treatment with blinatumomab in a child: A case report and review of the literature (2020) (5)
Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients (2020) (5)
[The role of interferons in neuroblastoma. 2: Immunomodulatory effects]. (1990) (5)
Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male (2003) (5)
Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell Transplantation. (2019) (5)
ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL (2019) (5)
Longtime outcome after intraosseous application of autologous mesenchymal stromal cells in pediatric patients and young adults with avascular necrosis after steroid or chemotherapy. (2020) (5)
Matched versus Haploidentical Hematopoietic Stem Cell Transplantation as Treatment Options for Primary Immunodeficiencies in Children. (2020) (5)
T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies (2021) (5)
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy (2022) (4)
Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia. (2009) (4)
No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease (2021) (4)
Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies (2019) (4)
Arsenic trioxide in pediatric cancer – a case series and review of literature (2021) (4)
NK cytotoxicity and alloreactivity against neuroblastoma cell lines in vitro: comparison of Europium fluorometry assay and quantification by RT-PCR. (2012) (4)
Long-term follow-up after the application of mesenchymal stromal cells in children and adolescents with steroid-refractory graft-versus-host disease. (2021) (4)
Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation (2010) (3)
Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors. (1994) (3)
Therapy Response Correlates with ALDH Activity in ALDH Low-Positive Childhood Acute Lymphoblastic Leukemias (2014) (3)
Clearance of Treatment Refractory Adenoviremia via Adenovirus-specific Donor T-Cell Transfer During Aplasia After αβTCR-CD19-Depleted Stem Cell Transplantation. (2018) (3)
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia—A prospective international multicenter trial on behalf of the BFM‐SG and the EBMT‐PDWP (2019) (3)
Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations (2016) (3)
The efficiency of a new cell separation technique in bone marrow purging without damaging the purged tumor cells. (1990) (3)
Abstract A013: Haploidentical stem cell transplantation and subsequent immunotherapy with antiGD2 antibody for patients with relapsed metastatic neuroblastoma (2019) (3)
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy (2022) (3)
Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL) (2002) (3)
Favorable immune recovery and low rate of GvHD in children transplanted with partially T cell-depleted PBSC grafts (2018) (3)
The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristics (2021) (3)
Haploidentical stem cell transplantation in children: Improved engraftment and immune recovery after depletion of T and B cells instead of positive selection of stem cells? (2006) (2)
iVacALL: utilizing next-generation sequencing for the establishment of an individual peptide vaccination approach for paediatric acute lymphoblastic leukaemia (2013) (2)
Prophylactic ribavirin treatment prevents adenovirus infection in pediatric stem cell transplant recipients (2003) (2)
Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens (2017) (2)
Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients (2019) (2)
Transplantation of CD34+ enriched allografts in children with nonmalignant diseases: does graft manipulation necessarily result in high incidence of graft failure? (2004) (2)
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial (2022) (2)
Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (2020) (2)
A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease. (2007) (2)
Haploidentical Stem Cell Transplantation in Children: A Comparison between Positive Selection of Stem Cells and Depletion of T- and B-Cells. (2005) (2)
Successful double umbilical cord blood transplantation for relapsed juvenile myelomonocytic leukemia (2013) (2)
Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning (2018) (2)
A chimeric CD 19 antibody mediates cytotoxic activity against leukemic blasts with effectors from pediatric patients transplanted with T cell depleted allografts (2004) (2)
Both mature KIR and immature KIR NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdc IL2rg/Sz mice (2014) (2)
Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma – a case report (2020) (2)
Dose Reduced Conditioning and CD3/CD19 Depletion for Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults: Fast Engraftment and Low Toxicity. (2005) (2)
Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas (2023) (2)
ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS (2016) (2)
Identification and selective depletion of alloreactive T-cells for adoptive immunotherapy. (2010) (2)
Determinants of antileukemia effects of allogeneic natural killer cells (2004) (2)
Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children. (2007) (2)
Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (2020) (1)
AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia (2017) (1)
Successful autologous stem cell transplantation (ASCT) in a patient with juvenile dermatomyositis (2008) (1)
Safety and Feasibility of Posaconazole as Oral Antifungal Prophylaxis In Pediatric Patients Under 12 Years of Age Following Allogeneic Stem Cell Transplantation. (2010) (1)
Hematopoietic stem cell transplantation with mesenchymal stromal cells in children with metachromatic leukodystrophy. (2022) (1)
Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature (2019) (1)
Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts (2013) (1)
Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody (2016) (1)
Adoptive Transfer of Hexon-Specific T-Cells as a Treatment of Adenovirus Reactivation Following Allogeneic Stem Cell Transplantation. (2009) (1)
An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia (2021) (1)
Consultations in Molecular Diagnostics Dynamics of the Emergence of a Human Cytomegalovirus UL97 Mutant Strain Conferring Ganciclovir Resistance in a Pediatric Stem-Cell Transplant Recipient (2009) (1)
123Iodine-metaiodobenzylguanidine scintigraphy versus whole-body magnetic resonance imaging with diffusion-weighted imaging in children with high-risk neuroblastoma — pilot study (2021) (1)
HHV6 Encephalitis in Children After Hematopoietic Stem Cell Transplantation (2017) (1)
Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab (2015) (1)
Immunological recovery following HLA‐matched CD3+ TCR αß+/CD19+ depleted hematopoietic stem cell transplantation in children (2022) (1)
Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors, (2011) (1)
CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. (2016) (1)
Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT (2013) (1)
From Bedside To Bench: Molecular Benchmarking Of An Fc-Optimized CD19 Antibody Used In Treatment Of Relapsed and Refractory Pediatric B-Lineage Acute Lymphoblastic Leukemia (2013) (1)
A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation (2012) (1)
Protective T-cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections. (2021) (1)
Faster Engraftment and Immune Reconstitution after Haploidentical Allogenic Hematopoietic Cell Transplantation with CD3/CD19 Depleted as Compared to CD34 Selected Grafts. (2005) (1)
Individualised Follow-Up for Patients after Haematopoietic Stem Cell Transplantation (HSCT) and Treatment for Relapse of Cancer (2012) (1)
Abstract A131: Targeting B7-H3 (CD276) in neuroblastoma: In vitro evaluation of Fc-optimized antibodies and immunocytokines (2019) (1)
Haematopoietic chimerism and donor lymphocyte infusion after allogeneic SCT in children with non-malignant disease: is there an option to improve outcome? (2004) (1)
Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study (2022) (1)
Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients (2018) (1)
The role of interferon-gamma in the immunotherapy of neuroblastoma. (1991) (1)
NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation (2022) (1)
Human Leukocyte Antigen Distribution in German Caucasians with Advanced Ewing’s Sarcoma (2012) (1)
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial. (2023) (1)
Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group (2008) (1)
Could (should) we abandon total body irradiation for conditioning in children with leukemia. (2022) (1)
Pediatric Patients Transplanted with Positive Selected Stem Cells from Alternative Donors Have a Low Incidence of CMV Dnaemia. (2004) (0)
The Potential Role of Natural Killer Cells in the Treatment of Malignant Disease (2008) (0)
Allogeneic NK Cells Determinants of Antileukemia Effects of (2003) (0)
Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication. (2010) (0)
HLA Identical Siblings Are the Best Donors for Children with ALL (2014) (0)
Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial (2016) (0)
Melphalan and cytarabine as a salvage therapy in children with relapsed or refractory acute leukemia (2020) (0)
Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation. (2012) (0)
Treatment of Adenovirus Infection After Haploidentical Stem Cell Transplantation in Children (2010) (0)
Adoptive Transfer of Adenovirus Specific T-Cells in Children with Systemic Adenovirus Infection after Allogeneic Stem Cell Transplantation. (2005) (0)
Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy (2022) (0)
[Mechanisms and treatment of primary type I hyperoxaluria]. (1996) (0)
Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial (2019) (0)
Allogeneic Stem Cell Transplantation (2018) (0)
Control Of Allograft Rejection With Mitomycin C Incubated Blood Cells (2013) (0)
Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation (2013) (0)
Clinical Grade Generation of T-Helper-1-Driven Polyclonal T-Cell Populations for Adoptive Immunotherapy Against Tumor Associated Antigens (2011) (0)
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (0)
Final results of a multicenter phase I/II study using CD3/CD19 depleted stem cells for haploidentical transplantation in children (2016) (0)
Risk factors for mixed chimerism after stem cell transplantation with treosulfan or melphalan based conditioning regimens in children and adolescents with primary hemophagocytic lymphohistocytosis (2018) (0)
Paediatric diseases (2001) (0)
Selective Allo-depletion: TcRαβ and CD19+ T-Cell Depletion (2018) (0)
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party (2023) (0)
Procalcitonin and C-Reactive Protein during Transplant-Related Adverse Events after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients (2018) (0)
Stem cell rescue from irradiation of multiple tumor sites combined with high-dose chemotherapy, followed by reduced intensity conditioning and allogeneic stem cell transplantation in patients with advanced pediatric sarcomas: Preliminary results of the MetaEICESS 2007 protocol. (2015) (0)
Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus Infections. (2021) (0)
A treosulfan-based toxicity-reduced conditioning regimen is safe and feasible for children with non-malignant diseases but increases rejection rates in stem cell transplantation of hemoglobinopathies (2016) (0)
Boosts with Highly Purified Stem Cells Can Improve Hematopoietic Regeneration after Allogeneic Transplantation from Alternative Donors. (2005) (0)
Antifungal prophylaxis with posaconazole suspension versus tablet in pediatric patients after hematopoietic stem cell transplantation (2016) (0)
depleted allografts - blasts with effector cells from pediatric patients who received T-cell Chimeric CD19 antibody mediates cytotoxic activity against leukemic (2013) (0)
Endoscopic treatment of acute cholecystitis (2000) (0)
Quantitative HLA Class I Expression and KIR-Mismatch between NK-Cell-Donor and Patient Predict NK Cell Mediated Lysis of Leukemic Cells from Children with Acute Lymphatic Leukemia. (2006) (0)
Transient but Reversible Activation Defect of T-Cell Responses Against Cytomegalovirus and Adenovirus through Immunosuppresion with Calcineurin Inhibitors. (2010) (0)
Alloreactivity of Natural Killer Cell Clones Against Childhood Precursor-B Lymphoblastic Leukemia Cells Is Determined by Differential KIR Expression. (2006) (0)
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft (2023) (0)
Candidemia in Patients with Hematological Malignancies: The Role of Prophilaxis and the Importance of Local Epidemiology for Treatment (2008) (0)
Retransplantation From Haploidentical Donors After Graft Failure in Pediatric Patients Results in Low Transplant Related Mortality and Favourable Long Term Survival (2011) (0)
Excellent response, low TRM and good survival in patients with therapy-refractory aGvHD after treatment with equipotent MSCs of a serum-free MSC-bank generated from pooled BM-MNCs of multiple donors. (2017) (0)
Abstract A080: Cytokine-induced senescence in neuroblastoma cell lines: Therapeutic option or idle wish? (2019) (0)
Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients. (2009) (0)
LB12 – Excellent response, low TRM and good survival in patients with therapy-refractory aGvHD after treatment with potency-defined doses of MSCs generated from a serum-free MSC-BANK of pooled BM-MNCS from multiple healthy donors (2017) (0)
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS FEASIBLE AFTER SOLID ORGAN TRANSPLANTATION: FINAL ANALYSIS BY THE EARLY COMPLICATIONS SUBCOMMITTEE OF THE COMPLICATIONS AND QUALITY OF LIFE WORKING PARTY, EBMT (2014) (0)
donors in pediatric leukemia Transplantation of highly purified CD34+ progenitor cells from unrelated (2013) (0)
DDDT_A_214264 3439..3451 (2019) (0)
Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT (2018) (0)
2.O.05 TRANSLATIONAL SARCOMA RESEARCH NETWORK (TRANSARNET) (2010) (0)
Hexon Specific T-Cells for Adoptive T-Cell Transfer as a Treatment of Adenovirus Infection after Allogeneic Stem Cell Transplantation. (2006) (0)
Osteonecrosis after Allogeneic HSCT in Children with High-Risk or Relapsed ALL Treated in the ALL-SCT 2003 Trial (2017) (0)
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens (2022) (0)
Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants (2016) (0)
Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants (2016) (0)
Long Term Survival And Relapse Rate After Transplantation Of Highly T And B Cell Depleted Stem Cells From Alternative Donors In Pediatric Patients With Acute Lymphatic Leukemia (2010) (0)
Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation (2021) (0)
Immune Reconstitution after Haploidentical Stem Cell Transplantation (2003) (0)
Paediatric diseases (2001) (0)
Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product MSC-Ffm Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients (2017) (0)
A Multidimensional Approach to Measuring Distress in Children Undergoing Hematopoietic Stem Cell Transplantation: Three Raters’ Perspectives and Stress Biomarkers in Saliva and Blood (2022) (0)
Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation. (2023) (0)
Use of Ex Vivo Graft Manipulation and Posttransplant Cyclophosphamide Result in Low GvHD Rates and Acceptable Engraftment after RIC Regimens in Pediatric Mismatched SCT (2019) (0)
GvHD and Engraftment after Haploidentical Stem Cell Transplantation. A Comparison of 3 Immunomagnetic Selection Procedures. (2004) (0)
The role of γδ T cells in the context of allogeneic stem cell transplantation (2022) (0)
Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (0)
Abstract 658: Translational theranostic imaging of lymphoma using radiolabeled αCD19-antibodies (2018) (0)
High Progenitor Cell Frequency at Diagnosis Predicts High Minimal residual Disease Level in Childhood ALL. (2009) (0)
Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation (2013) (0)
NK Cell Activity Influences Long Term Outcome of Pediatric Leucemias After T Cell Depleted Stem Cell Transplantation (2011) (0)
Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation. (2022) (0)
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation (2015) (0)
Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults with Reduced-Intensity Conditioning and CD3/CD19-Depleted Grafts: Low Toxicity and Fast Engraftment. (2006) (0)
Improved Immune Reconstitution with Low Incidence of Severe Graft-Versus-Host Disease after Transplantation of CD34+ or CD133+ Enriched Stem Cells with Add-Back of Ten Million T-Cells Per Kg. (2004) (0)
Improved T Cell Recovery After Transplantation Of CD3/CD19 Depleted Haploidentical Stem Cell Grafts In Pediatric Patients (2010) (0)
Transplantation of Megadoses of Highly Purified Haploidentical Stem Cells: Overcoming The HLA Barrier (1999) (0)
Interferon-Gamma Up-Regulates the Susceptibility of Human Neuroblastoma Cells to Natural Killer Cell-Mediated and Antibody-Dependent Cellular Cytotoxicity1 (1990) (0)
LYMPHOID NEOPLASIA Both mature KIR 1 and immature KIR 2 NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdc scid IL2rg tmWjl /Sz mice (2014) (0)
Transfer of Ex Vivo Expanded NK and γδT Cells from Untouched Posttransplant PBMCs to Clear Minimal Residual Disease in Acute Myeloid Leukemia (2014) (0)
6001 ORAL Immunosuppressive TLI-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoeitic stem cell transplantation (2007) (0)
THRIVING AS A TARGETED THERAPY IN AN IMMUNO-ONCOLOGY WORLD — LESSONS FROM THE MELANOMA , NSCLC AND RCC MARKETS (2018) (0)
Characterization of human MSC propagated in animal serum-free cultures and clinical application of MSC in paediatric patients. (2006) (0)
This information is current as Graft-versus-Host Disease Involved in the Pathogenesis of Cells and the Release of S100 Proteins Are Monocyte-Induced Development of Th17 (2014) (0)
Free Papers (2014) (0)
Haploidentical allogeneic haematopoietic cell transplantation with Cd34 selected stem cells for the treatment of haematologic malignancies: high survival and low incidence of Gvhd (2004) (0)
Transplantation of Haploidentical CD3/CD19 Depleted Stem Cells in Children: Final Results of a Multicenter Phase I/II Study (2016) (0)
Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia. (2009) (0)
Comment on ‘CD34+ selected hematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment of graft failure’ – G Milone et al (2005) (0)
Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation (2012) (0)
Expression of Activating Natural Killer Cell Receptor Ligands in Childhood Acute Lymphoblastic Leukemia. (2006) (0)
Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial (2013) (0)
Immunosuppressive TLI-Based Reconditioning Regimens Enable Engraftment After Graft Rejection or Graft Failure in Patients Treated With Allogeneic Hematopoeitic Stem Cell Transplantation (2007) (0)
Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia (2012) (0)
Transplantation of Positive Selected Peripheral Stem Cells with Add-Back of T Cells from Unrelated Donors in Children: Favourable Survival and Low Incidence of GvHD. (2006) (0)
Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies (2010) (0)
Abstract A140: A T-cell utilizing bispecific anti-CD3/GD2 construct mediates superior in vitro efficacy compared to CH14.18 mAb in neuroblastoma patients after allogeneic SCT (2019) (0)
Immunotherapeutic approaches for soft-tissue sarcoma: Augmentation of natural killer cell cytotoxicity by ex-vivo expansion and use of an anti-GD2 antibody. (2016) (0)
CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study. (2006) (0)
DDDT_A_260887 3915..3927 (2020) (0)
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing (2021) (0)
Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation (2008) (0)
NY-ESO-1 specific CD4+ Thelper1 cells for immunotherapy of cancer. (2014) (0)
Cytogenetically cryptic TNIP1-PDGFRB and PCM1-FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia (MLN-eo) in children (2021) (0)
Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia (2012) (0)
Paediatric diseases (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Peter J. Lang?

Peter J. Lang is affiliated with the following schools:

University of Erlangen–Nuremberg
Imperial College London
Hannover Medical School
University of Tübingen
Children's University